Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33

Journal of General Virology

Volumn 93, Issue 1, 2012, Pages 83-92

  Wang, Shanshan ^a   Wu, Xianfang ^a   Pan, Tingting ^a   Song, Wuhui ^a   Wang, Yaohui ^a   Zhang, Fei ^a   Yuan, Zhenghong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5A; PROTEIN HVAP 33; UNCLASSIFIED DRUG; VIPER VENOM; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEK293; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REPLICON; VIRUS INHIBITION; VIRUS REPLICATION;

CELL LINE; DOWN-REGULATION; HEPACIVIRUS; HEPATITIS C; HUMANS; PROTEIN BINDING; PROTEINS; VESICULAR TRANSPORT PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 83755183779     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.033860-0     Document Type: Article

References (32)

1. Aizaki, H., Lee, K. J., Sung, V. M., Ishiko, H. & Lai, M. M. (2004). Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324, 450-461.
2. Bartenschlager, R. & Lohmann, V. (2000). Replication of hepatitis C virus. J Gen Virol 81, 1631-1648.
3. Blight, K. J., Kolykhalov, A. A. & Rice, C. M. (2000). Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972-1974.
4. Boudinot, P., Riffault, S., Salhi, S., Carrat, C., Sedlik, C., Mahmoudi, N., Charley, B. & Benmansour, A. (2000). Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways. J Gen Virol 81, 2675-2682.
5. Chen, S. L. & Morgan, T. R. (2006). The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3, 47-52.
6. Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95, 15623-15628.
7. Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D. & Bienz, K. (2002). Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 76, 5974-5984.
8. El-Hage, N. & Luo, G. (2003). Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J Gen Virol 84, 2761-2769.
9. Evans, M. J., Rice, C. M. & Goff, S. P. (2004). Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A 101, 13038-13043.
10. Gao, L., Aizaki, H., He, J. W. & Lai, M. M. (2004). Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol 78, 3480-3488.
11. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. & Rice, C. M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385-1395.
12. Helbig, K. J., Lau, D. T., Semendric, L., Harley, H. A. & Beard, M. R. (2005). Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42, 702-710.
13. Hinson, E. R. & Cresswell, P. (2009a). The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc Natl Acad Sci U S A 106, 20452-20457.
14. Hinson, E. R. & Cresswell, P. (2009b). The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion. J Biol Chem 284, 4705-4712.
15. Huang, Y., Staschke, K., De Francesco, R. & Tan, S. L. (2007). Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? Virology 364, 1-9.
16. Jiang, D., Guo, H., Xu, C., Chang, J., Gu, B., Wang, L., Block, T.M. & Guo, J. T. (2008). Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82, 1665-1678.
17. Khaiboullina, S. F., Rizvanov, A. A., Holbrook, M. R. & St Jeor, S. (2005). Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression. Virology 342, 167-176.
18. Khu, Y. L., Tan, Y. J., Lim, S. G., Hong, W. & Goh, P. Y. (2004). Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity. Biochem J 384, 401-409.
19. Klotman, M. E. & Chang, T. L. (2006). Defensins in innate antiviral immunity. Nat Rev Immunol 6, 447-456.
20. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & other authors (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
21. McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M. H., Cort, S. & other authors (1998). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339, 1485-1492.
22. Miyanari, Y., Hijikata, M., Yamaji, M., Hosaka, M., Takahashi, H. & Shimotohno, K. (2003). Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. J Biol Chem 278, 50301-50308.
23. Moradpour, D., Penin, F. & Rice, C. M. (2007). Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463.
24. Salonen, A., Ahola, T. & Kääriäinen, L. (2005). Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol 285, 139-173.
25. Samuel, C. E. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14, 778-809.
26. Stetson, D. B. & Medzhitov, R. (2006). Type I interferons in host defense. Immunity 25, 373-381.
27. Taguchi, T., Nagano-Fujii, M., Akutsu, M., Kadoya, H., Ohgimoto, S., Ishido, S. & Hotta, H. (2004). Hepatitis C virus NS5A protein interacts with 29,59-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J Gen Virol 85, 959-969.
28. Tu, H., Gao, L., Shi, S. T., Taylor, D. R., Yang, T., Mircheff, A. K., Wen, Y., Gorbalenya, A. E., Hwang, S. B. & Lai, M. M. (1999). Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 263, 30-41.
29. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B. & Guatelli, J. (2008). The interferoninduced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252.
30. Yan, X. B., Battaglia, S., Boucreux, D., Chen, Z., Brechot, C. & Pavio, N. (2007). Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR. Virus Res 125, 79-87.
31. Yi, Z., Pan, T., Wu, X., Song, W., Wang, S., Xu, Y., Rice, C. M., Macdonald, M. R. & Yuan, Z. (2011). Hepatitis C virus co-opts Ras-GTPase-activating protein-binding protein 1 for its genome replication. J Virol 85, 6996-7004.
32. Zhao, J., Huang, Q., Wang, W., Zhang, Y., Lv, P. & Gao, X. M. (2007). Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 81, 6079-6088.